Peter Akerblad
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Erratum to: 'Inhibition of the renal apical sodium dependent bile acid transporter prevents cholemic nephropathy in mice with obstructive cholestasis' [J Hepatol (2024) 80:268-281].
Journal: Journal of hepatology
Published: March 16, 2025
Stage-dependent effects of systemic ASBT inhibition in a cholestasis-induced cholemic nephropathy mouse model.
Journal: JHEP reports : innovation in hepatology
Published: December 19, 2024
Inhibition of the renal apical sodium dependent bile acid transporter prevents cholemic nephropathy in mice with obstructive cholestasis.
Journal: Journal of hepatology
Published: March 28, 2023
A3907, a systemic ASBT inhibitor, improves cholestasis in mice by multiorgan activity and shows translational relevance to humans.
Journal: Hepatology (Baltimore, Md.)
Published: September 28, 2022
IDOL regulates systemic energy balance through control of neuronal VLDLR expression.
Journal: Nature metabolism
Published: February 20, 2020
A high-content, in vitro cardiac fibrosis assay for high-throughput, phenotypic identification of compounds with anti-fibrotic activity.
Journal: Journal of molecular and cellular cardiology
Published: December 11, 2019
Structural analysis identifies an escape route from the adverse lipogenic effects of liver X receptor ligands.
Journal: Communications biology
Published: July 19, 2019
Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice.
Journal: Molecular metabolism
Published: December 08, 2018
High-content phenotypic assay for proliferation of human iPSC-derived cardiomyocytes identifies L-type calcium channels as targets.
Journal: Journal of molecular and cellular cardiology
Published: January 09, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026